Cambridge to be new location for GlaxoSmithKline research center

December 23, 2013 by  

GlaxoSmithKline, a British pharmaceutical company, recently announced that it will be opening a new research and development center in Cambridge early in 2014. No doubt the company is using flyer printing and poster printing to let those in the community and the Greater Boston area become aware of this expansion of the company.

According to a United States spokeswoman for GlaxoSmithKline, Melinda Stubbee, the office in Cambridge will have a small network of employees. During the first quarter of 2014, the company will be hiring someone to lead the research efforts and looking for office space.

GlaxoSmithKline has its North American headquarters in Research Triangle Park, North Carolina where 4,000 people are employed, as well as 600 people working in a manufacturing plant in Zebulon. This move, along with a plan to open an office in San Diego, is part of the company’s efforts to increase its research presence around the world.

A GlaxoSmithKline senior vice president, Lon Cardon, added that this move enables the company to have access to one of the largest research communities in the world so as to facilitate the ability of the company to mix its expertise with that of local entrepreneurs and academics.

Even after a pullback from the research begun with the purchase of Sitris Pharmaceuticals in 2008, GlaxoSmithKline has continued to collaborate with various academics in the Boston area, including the Stem Cell Institute at Harvard. It has a majority ownership in Tempero Pharmaceuticals which is working to develop treatments for such conditions as psoriasis, inflammatory bowel disease, rheumatoid arthritis, lupus, and multiple sclerosis.